These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9794099)

  • 1. Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus--a population-based study.
    Mühlhauser I; Overmann H; Bender R; Bott U; Jörgens V; Trautner C; Siegrist J; Berger M
    Diabetologia; 1998 Oct; 41(10):1139-50. PubMed ID: 9794099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
    Mühlhauser I; Overmann H; Bender R; Jörgens V; Berger M
    Diabet Med; 2000 Oct; 17(10):727-34. PubMed ID: 11110506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.
    Sämann A; Mühlhauser I; Bender R; Kloos Ch; Müller UA
    Diabetologia; 2005 Oct; 48(10):1965-70. PubMed ID: 16132954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up.
    Plank J; Köhler G; Rakovac I; Semlitsch BM; Horvath K; Bock G; Kraly B; Pieber TR
    Diabetologia; 2004 Aug; 47(8):1370-5. PubMed ID: 15258736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults.
    Carlsen S; Skrivarhaug T; Thue G; Cooper JG; Gøransson L; Løvaas K; Sandberg S
    Pediatr Diabetes; 2017 May; 18(3):188-195. PubMed ID: 26875589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified insulin therapy and the risk of severe hypoglycaemia.
    Bott S; Bott U; Berger M; Mühlhauser I
    Diabetologia; 1997 Aug; 40(8):926-32. PubMed ID: 9267987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000].
    Schiel R; Müller UA
    Med Klin (Munich); 2003 Jun; 98(6):303-12. PubMed ID: 12811414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R; Ulbrich S; Müller UA
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes.
    Müller N; Kloos C; Sämann A; Wolf G; Müller UA
    Patient Educ Couns; 2013 Oct; 93(1):108-13. PubMed ID: 23747089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
    Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
    Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy.
    Bott U; Bott S; Hemmann D; Berger M
    Diabet Med; 2000 Sep; 17(9):635-43. PubMed ID: 11051282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current clinical status, glucose control, and complication rates of children and youth with type 1 diabetes in Rwanda.
    Marshall SL; Edidin D; Sharma V; Ogle G; Arena VC; Orchard T
    Pediatr Diabetes; 2013 May; 14(3):217-26. PubMed ID: 23279222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COST-EFFECTIVENESS OF STRUCTURED EDUCATION IN CHILDREN WITH TYPE-1 DIABETES MELLITUS.
    Basarir H; Brennan A; Jacques R; Pollard D; Stevens K; Freeman J; Wales J; Price K
    Int J Technol Assess Health Care; 2016 Jan; 32(4):203-211. PubMed ID: 27719689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.